Titan Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 11, 2022 at 10:18 pm
Titan Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 0.15 million compared to USD 0.445 million a year ago. Net loss was USD 2.46 million compared to USD 1.68 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.17 a year ago.
For the six months, revenue was USD 0.341 million compared to USD 1.13 million a year ago. Net loss was USD 5 million compared to USD 4.32 million a year ago. Basic loss per share from continuing operations was USD 0.41 compared to USD 0.45 a year ago.